PLACEMENT AGENT COMMON STOCK PURCHASE WARRANTCleveland Biolabs Inc • February 23rd, 2021 • Pharmaceutical preparations • New York
Company FiledFebruary 23rd, 2021 Industry JurisdictionTHIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after February 23, 2021 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on February 19, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Cleveland BioLabs, Inc., a Delaware corporation (the “Company”), up to ______ shares of Common Stock (the shares of Common Stock issuable upon exercise hereof being referred to as the “Warrant Shares”) The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between the Company and H.C. Wainwright & Co., LLC, dated as of February 19, 2021.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 23rd, 2021 • Cleveland Biolabs Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 23rd, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of February 19, 2021, between Cleveland BioLabs, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).